ERNA vs REG · P/E 0.0, rev $582.0K vs P/E 34, $12.93B cap
Eterna Therapeutics Inc (ERNA) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
REG does not have a complete income-statement cache yet.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the ERNA and REG stock pages for the full models.
Not investment advice.